Krystal Biotech IncHere is the public summary page for Krystal Biotech Inc. Please login to see the complete information for Krystal Biotech Inc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Krystal Biotech Inc stacks up relative to its peers. |
| Darwin Score | +22 |
| Ticker | KRYS |
| Latest Price | 263.80 USD as of close on 03-Mar-2026 |
| 3 Month price range | 217.46 to 291.93 USD |
| Market Capitalisation | 8.06Bn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB105, which is in Phase 1/2 clinical trials for treating patients with deficient autosomal recessive congenital ichthyosis; KB104 for treating netherton syndrome; KB407 that is in Phase 1 clinical trials for treating cystic fibrosis; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania. See More ... |
| Company URL | https://www.krystalbio.com |
| See Darwins Full Analysis for Krystal Biotech Inc |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Krystal Biotech Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | +13 |
| Sentiment | News and Candle Patterns. | 0 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | 0 |
| Flow | Institutional, Fund and Insider buying and selling. | -8 |
| Models | Forecast models. | +17 |
Alerts
There are 5 live alerts for Krystal Biotech Inc. All the alerts are negative.
- New Low (1m). (Negative)
- 5d RSI Oversold. (Negative)
- Cross Over (Down):5dma . (Negative)
- Cross Over (Down):50dma . (Negative)
- Cross Over (Down):20dma . (Negative)
Peer Comparison
There are 27 peers of Krystal Biotech Inc.
Share 
